Cargando…

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor

Glucagon-like peptides (GLP-1 and GLP-2) are two proglucagon-derived intestinal hormones that mediate distinct physiological functions through two related receptors (GLP-1R and GLP-2R) which are important drug targets for metabolic disorders and Crohn’s disease, respectively. Despite great progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wen, Chen, Li-Nan, Zhou, Qingtong, Zhao, Li-Hua, Yang, Dehua, Zhang, Huibing, Cong, Zhaotong, Shen, Dan-Dan, Zhao, Fenghui, Zhou, Fulai, Cai, Xiaoqing, Chen, Yan, Zhou, Yan, Gadgaard, Sarina, van der Velden, Wijnand J. C., Zhao, Suwen, Jiang, Yi, Rosenkilde, Mette M., Xu, H. Eric, Zhang, Yan, Wang, Ming-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785020/ https://www.ncbi.nlm.nih.gov/pubmed/33239759 http://dx.doi.org/10.1038/s41422-020-00442-0

Ejemplares similares

Structural basis for activation of the growth hormone-releasing hormone receptor
por: Zhou, Fulai, et al.
Publicado: (2020)

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
por: Zhao, Fenghui, et al.
Publicado: (2022)

Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long‐term impairment of the GIP system
por: Gabe, Maria Buur Nordskov, et al.
Publicado: (2019)

Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors
por: Feng, Wenbo, et al.
Publicado: (2023)

Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023)

Constitutive signal bias mediated by the human GHRHR splice variant 1
por: Cong, Zhaotong, et al.
Publicado: (2021)

Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor
por: Cong, Zhaotong, et al.
Publicado: (2021)

Molecular and in vivo phenotyping of missense variants of the human glucagon receptor
por: van der Velden, Wijnand J.C., et al.
Publicado: (2021)

N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction
por: Gabe, Maria Buur Nordskov, et al.
Publicado: (2022)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
por: Zhao, Fenghui, et al.
Publicado: (2021)

Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening
por: Zhou, Qingtong, et al.
Publicado: (2021)

Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24
por: Cong, Zhaotong, et al.
Publicado: (2022)

Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)
por: Chen, Yan, et al.
Publicado: (2023)

Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activation
por: Liu, Xiao, et al.
Publicado: (2021)

Molecular basis of signal transduction mediated by the human GIPR splice variants
por: Zhao, Fenghui, et al.
Publicado: (2023)

Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2
por: Wang, Xi, et al.
Publicado: (2021)

Modulating effects of RAMPs on signaling profiles of the glucagon receptor family
por: Shao, Lijun, et al.
Publicado: (2022)

GPR160 is a potential biomarker associated with prostate cancer
por: Guo, Wanjing, et al.
Publicado: (2021)

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2
por: Xu, Yingna, et al.
Publicado: (2022)

Crystal structure of a constitutive active mutant of adenosine A(2A) receptor
por: Cui, Min, et al.
Publicado: (2022)

Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats
por: Pedersen, Christina, et al.
Publicado: (2018)

Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats
por: Pedersen, Christina, et al.
Publicado: (2018)

High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist
por: Lin, Guangyao, et al.
Publicado: (2021)

Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation
por: Zhou, Yanni, et al.
Publicado: (2022)

Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
por: Galsgaard, Katrine D., et al.
Publicado: (2022)

Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission
por: Zhang, Bo, et al.
Publicado: (2016)

Tail engagement of arrestin at the glucagon receptor
por: Chen, Kun, et al.
Publicado: (2023)

Loss of Adgra3 causes obstructive azoospermia with high penetrance in male mice
por: Nybo, Maja L., et al.
Publicado: (2023)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Common activation mechanism of class A GPCRs
por: Zhou, Qingtong, et al.
Publicado: (2019)

G protein-coupled receptors: structure- and function-based drug discovery
por: Yang, Dehua, et al.
Publicado: (2021)

High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening
por: Qin, Shanshan, et al.
Publicado: (2018)

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
por: Zhao, Dehua, et al.
Publicado: (2023)

The links between adipose tissue DNA methylation, obesity, and insulin resistance: A protocol for systematic review
por: Li, Suwen, et al.
Publicado: (2022)

The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression
por: Ge, Yunjun, et al.
Publicado: (2014)

A Founder Pathogenic Variant of PPIB Unique to Chinese Population Causes Osteogenesis Imperfecta IX
por: Zhu, Wenting, et al.
Publicado: (2021)

Generation of glucagon‐like peptide‐2‐expressing Saccharomyces cerevisiae and its improvement of the intestinal health of weaned rats
por: Zhang, Zhongwei, et al.
Publicado: (2016)

Glucagon-like peptide-1 analogue exendin-4 modulates serotonin transporter expression in intestinal epithelial cells
por: Cui, Xiufang, et al.
Publicado: (2020)

Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data
por: Zhao, Zhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v34ib88vdpbf4lc0en51jmjhk2